国际眼科杂志Issue(2)：266-269,4.DOI:10.3980/j.issn.1672-5123.2014.02.18
早产儿视网膜病变治疗新进展
Current treatment progress on retinopathy of prematurity
田丽丽 1任兵 2高晓唯3
作者信息
- 1. 830002 中国新疆维吾尔自治区石河子市，石河子大学医学院
- 2. 830013 中国新疆维吾尔自治区乌鲁木齐市，解放军第474医院全军眼科中心
- 3. 830013 中国新疆维吾尔自治区乌鲁木齐市，解放军第474医院全军眼科中心
- 折叠
摘要
Abstract
Retinopathy of prematurity ( ROP ) is a disease of retinal vascular proliferative lesions which occurs in premature and low birth weight infants.The incidence is increasing in view of the rising numbers of preterm deliveries and improved neonatal care. Traditional modalities of treatment include cryotherapy and laser therapy, which are laborious and require special training.Hence, research is on the way to find novel treatment modalities used for early stage of the disease with the characteristics of easy operation, safety and efficacy. We reviewed the published and unpublished literature on newer methods of ROP management.关键词
早产儿视网膜病变/抗血管内皮生长因子/胰岛素样生长因子-1/促红细胞生成素/基因治疗Key words
retinopathy of prematurity/anti-vascular endothelial growth factor/insulin-like growth factor-1/erythropoietin/gene therapy引用本文复制引用
田丽丽,任兵,高晓唯..早产儿视网膜病变治疗新进展[J].国际眼科杂志,2014,(2):266-269,4.
